Zelapar 1.25 MG Disintegrating Oral Tablet

RxCUI: 859192
RxNorm name: Zelapar 1.25 MG Disintegrating Oral Tablet
Display name: Zelapar 1.25 MG Disintegrating Oral Tablet
Full name: Zelapar 1.25 MG Disintegrating Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ZELAPAR	SELEGILINE HYDROCHLORIDE	Bausch Health US, LLC	380d7717-2a79-42f3-a712-efe5e7696ba0	2021-06-01	Warnings, Adverse reactions	Exact identifier rxcui: 859192

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
380d7717-2a79-42f3-a712-efe5e7696ba0	Zelapar 1.25 MG Disintegrating Oral Tablet [PSN] · selegiline hydrochloride 1.25 MG Disintegrating Oral Tablet [Zelapar] [SBD] · Zelapar 1.25 MG Disintegrating Oral Tablet [SY]	3	12	These highlights do not include all the information needed to use ZELAPAR safely and effectively. See full prescribing information for ZELAPAR. ZELAPAR ® (selegiline hydrochloride) orally disintegrating tablets Initial U.S. Approval: 2006	20210601